Behind the scenes part two: Where are we at with treatments for coronavirus SARS-CoV-2?

COVID-19 | LOCAL PROFESSIONAL ADVICE



While the global society is getting used to the daily media coverage of COVID-19 case numbers, lots of scientists all over the world are working hard to explore possible treatments.

The emphasis must be on “possible” treatments - as to date no confirmed and approved treatment is available.


RELATED:
- Behind the scenes part one: testing for coronavirus


Let’s have a look at some of the different angles:

  1. Given SARS-CoV-2 is a virus - it makes sense to look for an antiviral treatment. Antiviral medications work by trying to stop a virus from growing. Currently at least 10 trials are underway - so far with mixed results.

  2. Antimalarial medication has attracted a lot of attention, especially in the USA. While early reports were able to report beneficial outcomes for some patients, formal large scale randomised trials need to be conducted to look at safety and at what kind of patients might benefit. Anecdotal success stories are not enough to determine if such a treatment can be used for a wider population.

  3. Another group of medication is the group of immunosuppressants - especially as the over stimulation of a person’s immune response caused by SARS-CoV-2 seems to contribute to a higher risk of dying. These drugs are often used in the treatment of Multiple Sclerosis or Rheumatoid Arthritis.

  4. Stem-cell-therapy is another avenue scientists are looking at, but this trial is still in a very early phase.

  5. Then there are at least a dozen trials exploring the use of plasma from recovered patients, to provide neutralising antibodies . However, when this approach was trialled in 2014 during the Ebola outbreak, a study with 84 Ebola patients found no improvement in survival.

So, while it is comforting to know that scientists are searching for treatments, the reality is that we are still very far away from being able to treat COVID-19 patients with severe symptoms other than through supportive therapies such as artificial ventilation.

But, and this is a big and happy but, why don’t we turn to the things we already know?

We do know for example that in over 80% of people with coronavirus, our very own inbuilt immune system works just perfectly to fight the virus.

80% is quite a big success rate - and in my opinion, we should do everything we can to help our immune system to do its job.

This also means the ball is in our hands. Instead of sitting it out & waiting for a cure, let’s get started and become serious about improving our lifestyle! Ditch the cigarettes, eat whole food and get active - it is never too late to start with your better life.


Newsport Community Service Support:

Business support line:
business.gov.au | 13 28 46

Small or medium business with reduced cash flow?
Here’s what we’re doing to boost your cash flow.

Is your business financially distressed?
This is what we’re doing to support you.

Assisting the economic recovery
Here’s how we’ll support you to grow.

Employ an apprentice or trainee?
This support is for you.

Are you a sole trader that has lost business?
This is what we’re doing to support you and your business.

Household finances hit by reduced work?
Here’s what we’re doing to help support your family budget.


Letters to the Editor. Do you have an opinion or point of view you'd like to share on one of our stories or a community issue? Please submit here.

* Readers are encouraged to use their full details to ensure letter legitimacy. Letters are the opinions of readers and do not represent the views of Newsport or its staff. Letters containing unlawful, obscene, defamatory or abusive material will not be published.


Got a great news tip or video? We'd love to see it. Send news tips to editor@newsport.com.au


* Comments are the opinions of readers and do not represent the views of Newsport or its staff.
Reader comments on this site are moderated before publication to promote valuable, civil, and healthy community debate. Our moderation takes into consideration these guidelines and rules before comments are approved for publication.